Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722173 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
1 - 5 UsersAdd to Basket



2005 The Worldwide Biochips & Equipments Market
Fuji-Keizai USA, Inc., June 2005


  Description  
  Table of Contents  
  Companies Mentioned  
    
    
   
 Enquire before Buying  
 Send to a Friend  

This study provides a broad review of the biochip business roadmap as the market progresses through 2005. What is interesting about biochips is that the field is changing fast. Biochips are becoming more diverse and customers are appearing in other world regions such as China and India. The products from the biochip market are being used to help accelerate the research processes and capabilities of bio-pharmaceutical drug discovery and basic academic bioresearch.

During the past ten years, major pharma companies have seen their R&D costs explode as their actual productivity has declined. Drug companies have looked outside of their labs to find drug products faster. As a result, pharma companies have increasingly become motivated research and financial partners with many biotechnology companies. At the same time, pharma companies also want to become customers and partners of biochip companies because these companies have technologies that might help them become more productive faster.

New business models are being created. The ideas of pharmacogenomics and targeted therapies have received positive reception from government regulators. Roche and Affymetrix were the first to receive FDA approval for a biochip-based molecular diagnostic test and instrument system.

Basic academic research is helping too. Accelerating the drug making process requires modern industrialization of R&D, by using genomics and proteomics technologies such as biochips that the biotechnology companies provide.

This report discusses these important topics with interesting findings. This study has found that the total biochip market size in 2004 is about $2.0 billion and is projected to grow to about $5.1 billion in 2009 with a CAGR of 20.2%. The strategies of 29 firms are reviewed. This study uses more than 60 figures and tables to illustrate the findings.


Customers who bought this item also bought

Biochip Trends for Drug R&D and Diagnostics -- Companies, Equipment, Consumables, Software, Services and World Market

Biochip Trends for Drug R&D and Diagnostics – Companies, Equipment, Consumables, Software, Services and World Market

2007 The Worldwide Biochip & Equipment Market

2007 The Worldwide Biochip & Equipment Market

The US Biochip and Equipment Market and Business - 2003 Edition Technology Trends, Market and Business Trends, Sales, and Distribution

World Biochip Markets

Biochips - Global Strategic Business Report

Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers

Biochips - A Global Update of Market Trends & Opportunities

Biochips in Drug Discovery in Europe

DNA Sequencing 2008

Emerging Technologies in Lab-on-a-Chip: Microarrays and Biochips (Technical Insights)



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds